期刊文献+

小鼠PD-1胞外段的克隆、原核表达及活性分析 被引量:3

Cloning and expression of the mouse sPD-1 as well as its biological activity analysis
原文传递
导出
摘要 目的小鼠PD-1胞外段(ePD-1)原核表达载体的构建、表达、纯化及其生物学效应初步研究。方法应用小鼠脾细胞总RNA,采用RT-PCR克隆PD-1胞外段基因,将其重组到原核表达载体pGEX-4T-1中,构建原核表达载体pGEX-4T-1-ePD-1,转化至E.coli DH5α,筛选阳性菌落,进行酶切及测序鉴定。将测序正确的重组表达质粒pGEX-4T-1-ePD-1转化至E.coli BL21(DE3)中,经IPTG诱导表达后,对表达产物进行SDS-PAGE和Western blot检测,同时通过蛋白质纯化仪纯化GST-ePD-1融合蛋白。利用流式细胞术和Alamar Blue法,检测纯化的PD-1胞外段融合蛋白对淋巴细胞增殖的影响,评价其生物学活性。结果成功构建重组质粒pGEX-4T-1-ePD-1,并在E.coli BL21(DE3)中获得了成功表达,利用蛋白质纯化仪得到纯化的GST-ePD-1融合蛋白。流式细胞术和Alamar Blue法结果均显示,不同浓度的融合蛋白作用于混合淋巴细胞,与阴性对照相比,可明显促进淋巴细胞的增殖。结论成功地克隆、表达和纯化了小鼠ePD-1蛋白,纯化的重组蛋白可有效促进淋巴细胞增殖,为进一步研究其功能和临床应用提供了条件。 To investigate the biological activity of mouse PD-1 ectodomain(ePD-1),we cloned and expressed ePD-1 gene. ePD-1 gene was amplified from mouse spleen cell mRNA by RT-PCR,and then cloned into prokaryotic expression vector pGEX-4T- 1,for screening positive recombinant plasmid pGEX-4T-1-ePD-1 by enzyme digestion and sequencing.Then the correct sequence of the recombinant plasmid was transformed into E.coli BL21,and induced by IPTG.The expressed recombinant protein was analyzed by SDS-PAGE and Western blotting;the fusion protein was purified by GSTrap FF affinity chromatograph on the Protein Purification System, and then analyzed by Alamar Blue assay and flow cytometry(FCM) for evaluating its biological activity.While the results of Alamar Blue assay and Flow cytometry showed that the fusion protein added to the mixed lymphocytes could significantly promote the proliferation of lymphocytes,as compared with the negative control.All these data mean that the purified recombinant protein can be effective in promoting lymphocyte proliferation,which can be used for further research in the function and clinical application of ePD- 1.
出处 《免疫学杂志》 CAS CSCD 北大核心 2010年第5期403-407,共5页 Immunological Journal
基金 三峡大学研究生科研创新基金项目(2009-36)
关键词 小鼠PD-1胞外段 融合蛋白 蛋白纯化 淋巴细胞增殖 Mouse ePD-1 Fusion protein Protein purification Lymphocyte proliferation
  • 相关文献

参考文献10

  • 1Ebelt K, Babaryka G, Frankenberger B, et al. Prostate cancer lesions are surrounded by FOXP3^+,PD-1^+ and B7-H1^+ lymphocyte clusters [J]. Eur J Cancer, 2009, 45 (9): 1664-1672.
  • 2Li B, VanRoey M, Wang C, et al. Anti-programmed death-1 synergizes with granulocyte macrophage colony-stimulating factor--secreting tumor cell immunotherapy providing therapeutic benefit to mice with established tumors [J]. Clin Cancer Res, 2009,15(5): 1623-1634.
  • 3Gao Q, Wang XY, Qiu SJ, et al. Overexpression of PD-L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinoma [J]. Clin Cancer Res, 2009,15(3):971-979.
  • 4Kozako T, Yoshimitsu M, Fujiwara H, et al. PD-1/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia/lymphoma patients[J]. Leukemia, 2009,23(2):375-382.
  • 5Blank C, Mackensen A. Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion [J]. Cancer Immunol Immunother, 2007, 56 (5): 739-745.
  • 6Zhang C, Wu S, Xue X, et al. Anti-tumor immunotherapy by blockade of the PD-1/PD-L1 pathway with recombinant human PD- 1-IgV[J]. Cytotherapy, 2008,10(7):711-719.
  • 7Urbani S, Amadei B, Tola D, et al. Restoration of HCV-specific T cell functions by PD-1/PD-L1 blockade in HCV infection: effect of viremia levels and antiviral treatment[J]. J Hepatol, 2008, 48(4):548-558.
  • 8Li N, Qin H, Li X, et al. Potent systemic antitumor immunity induced by vaccination with chemotactic-prostate tumor associated antigen gene-modified tumor cell and blockade of B7-H1 [J]. J Clin Immunol, 2007, 27(1):117-130.
  • 9Onlamoon N, Rogers K, Mayne AE, et al. Soluble PD-1 rescues the proliferative response of simian immunodeficiency virus-specific CD4 and CD8 T cells during chronic infection [J]. Immunology, 2008, 124(2):277-293.
  • 10邵永,王槐志,董家鸿.PD-L1分子与疾病免疫调节[J].免疫学杂志,2008,24(5):591-594. 被引量:10

二级参考文献27

  • 1张淑敏,畅继武,马富玲,隋志方,王馨,张新,刘凤勇.用糖基化磷脂酰肌醇B7-1锚定肿瘤细胞膜进行免疫治疗[J].免疫学杂志,2007,23(3):323-326. 被引量:4
  • 2Dong H, Zhu G, Tamada K, et al. B7-H1, a third member of the B7 family, costimtdates T cell proliferation and intedeukin 10 secretion [J]. Nat Med, 1999, 5 (12): 1 365-1 369.
  • 3Butte MJ, Keir ME, Phamduy TB, et al. Phamduy, et al.Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses [ J]. Immunity, 2007, 27 ( 1 ) : 111 - 122.
  • 4Iwai Y, Ishida M, Tanaka Y, et al. Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade[J]. Proc Natl Acad Sci USA, 2003, 99 (19) : 12 293 - 12 297.
  • 5Tamura H, Dong H, Zhu G, et al. B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function [J]. Blood, 2001, 97 (6): 1 809- 1 816.
  • 6Chen CH, Kuo LM, Chang Y, et al. In vivo immune modulatory activity of hepatic stellate cells in mice [ J ]. Hepatology, 2006, 44 (5) : 1 171 - 1 181.
  • 7Keir ME, Hang SC, Guleria I, et al. Tissue expression of PD-L1 mediates peripheral T cell tolerance [ J]. Exp Med, 2006, 203 (4): 883- 895.
  • 8Wenda Gao, Gulcin Demirci, Terry B, et al. Stimulating PD-1 negative signals concttrrent with blocking CD154 costimulation induces long term islet allograft survival [ J ]. Transplantation, 2003, 76 (6): 994- 999.
  • 9Subudhi SK, Zhou P, Yerian LM, et al. Local expression of B7-H1 promotes organ specific autoimmunity and transplant rejection [J]. Clin Invest, 2004, 113 (5): 694-700.
  • 10Koga N, Suzuki J, Kosuge H, et al. Blockade of the interaction between PD-1 and PD-L1 accelerates graft arterial disease in cardiac allografts [J]. Arterioscler Thromb Vasc Biol, 2004, 4 ( 11 ) : 2 057 - 2 062.

共引文献9

同被引文献36

  • 1Kozako T, Yoshimitsu M, Fujiwara H, et al. PD-1/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia/lymphoma patients [J]. Leukemia, 2009, 23(2):375-382.
  • 2Urbani S, Amadei B, Tola D, et al. Restoration of HCV-spe- cific T cell functions by PD-1/PD-L1 blockade in HCV in- fection: effect of viremia levels and antiviral treatment [J]. J Hepatol, 2008, 48(4):548-558.
  • 3Onlamoon N, Rogers K, Mayne AE. Soluble PD-1 rescues the proliferative response of simian immunodeficiency virus-specific CD4 and CD8 T ceils during chronic infection [J]. Immunology, 2008, 124(2):277-293.
  • 4Gao Q, Wang XY, Qiu SJ, et al. Overexpression of PD-L1 significantly associates with tumor aggressiveness and post- operative recurrence in human hepatocellular carcinoma [J]. Clin Cancer Res, 2009, 15(3): 971-979.
  • 5Reynoso ED, Elpek KG, Francisco L, et al. Intestinal toler- ance is converted to autoimmune enteritis upon PD-1 ligand blockade [J]. J Immunol, 2009, 182(4): 2102-2112.
  • 6Keir ME, Butte MJ, Freeman GJ, et al. PD-1 and its ligands in tolerance and immunity [J]. Annu Rev Immunol, 2008, 26: 677-704.
  • 7Sharpe AH, Wherry E J, Ahmed R, et al. The function of pro- grammed cell death 1 and its ligands in regulating autoimmunity and infection [J]. Nat Immunol, 2007, 8(3): 239-245.
  • 8Jacobs JF, Idema A J, Bol KF, et al. Regulatory T cells and the PD-L1/PD-1 pathway mediate immune suppres- sion in malignant human brain tumors [J]. Neuro Oncol. 2009, 11(4): 394-402.
  • 9Wang W, Lau R, Yu D, et al. PD1 blockade reverses the suppression of melanoma antigen-specific CTL by CD4+ CD25 (Hi) regulatory T cells [J]. Int Immunol. 2009, 21 (9): 1065-1077.
  • 10Habicht A, Dada S, Jurewicz M, et al. A link between PDLI and T regulatory cells in fetomaternal tolerance [J]. J hn- munol. 2007, 179(8): 5211-5219.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部